Elk Creek Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-1,866
| Closed | -$252K | – | 135 |
|
|
2019
Q1 | $252K | Sell |
1,866
-770
| -29% | -$104K | 0.02% | 127 |
|
|
2018
Q4 | $257K | Sell |
2,636
-1,943
| -42% | -$189K | 0.02% | 127 |
|
|
2018
Q3 | $637K | Hold |
4,579
| – | – | 0.03% | 128 |
|
|
2018
Q2 | $568K | Sell |
4,579
-64
| -1% | -$7.94K | 0.03% | 130 |
|
|
2018
Q1 | $518K | Buy |
4,643
+800
| +21% | +$89.3K | 0.03% | 136 |
|
|
2017
Q4 | $460K | Buy |
3,843
+54
| +1% | +$6.46K | 0.03% | 137 |
|
|
2017
Q3 | $532K | Buy |
3,789
+92
| +2% | +$12.9K | 0.03% | 132 |
|
|
2017
Q2 | $450K | Buy |
3,697
+1,061
| +40% | +$129K | 0.03% | 131 |
|
|
2017
Q1 | $320K | Buy |
+2,636
| New | +$320K | 0.02% | 142 |
|
|
2015
Q2 | – | Sell |
-3,780
| Closed | -$655K | – | 170 |
|
|
2015
Q1 | $655K | Sell |
3,780
-743
| -16% | -$129K | 0.07% | 159 |
|
|
2014
Q4 | $837K | Buy |
+4,523
| New | +$837K | 0.11% | 149 |
|